Strategic Buyout Dextrys is now an EPAM company backed by Francisco Partners, signaling strong financial backing and potential cross-sell opportunities with EPAM's enterprise clients and portfolio.

Global Delivery Footprint With focus on software development, maintenance, and testing services for technology-driven firms worldwide, there is potential to expand into new geographies and leverage EPAM’s global delivery capabilities.

Mid-market Power Operating at 51-200 employees with revenue in the hundreds of millions, target mid-market enterprises seeking scalable software and quality assurance partnerships could be a key sales lane.

Cost-Optimization Dextrys emphasizes reducing software development costs and faster time-to-market, presenting opportunities for clients pursuing agile cost-saving programs and rapid product launches.

Tech-Driven Reliability As a high-value provider of development, maintenance, and testing, position Dextrys for clients needing end-to-end quality assurance and continuous delivery capabilities, potentially co-sell with EPAM’s broader tech stack.